Maplight Therapeutics
Clinical trials sponsored by Maplight Therapeutics, explained in plain language.
-
New autism drug trial aims to ease social struggles
Symptom relief OngoingThis study is testing an investigational medicine called ML-004 to see if it can help improve social communication and other core challenges in teens and adults with autism. About 150 participants will be randomly assigned to receive either the real medicine or a placebo (a look-…
Phase: PHASE2 • Sponsor: MapLight Therapeutics • Aim: Symptom relief
Last updated Mar 30, 2026 14:30 UTC
-
Autism drug safety trial opens for Long-Term Follow-Up
Symptom relief ENROLLING_BY_INVITATIONThis study is a follow-up to check the long-term safety of an investigational medicine called ML-004 in people with autism. It will enroll about 120 adolescents and adults who recently finished a previous ML-004 study. The main goal is to monitor for any side effects or safety is…
Phase: PHASE2 • Sponsor: MapLight Therapeutics • Aim: Symptom relief
Last updated Mar 27, 2026 12:38 UTC